Nykode Therapeutics ASA
NYKD | OL
Overview
Corporate Details
- ISIN(s):
- NO0010714785
- LEI:
- 254900UKQHWYZJD22017
- Country:
- Norway
- Address:
- Gaustadalleen 21, 0349 Oslo
- Website:
- https://nykode.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies and vaccines. The company's core technology is its proprietary and modular Vaccibody™ platform, designed to elicit fast, strong, and long-lasting immune responses by targeting antigens to Antigen Presenting Cells. This pioneering approach is being applied to develop treatments for a wide range of diseases, with a primary focus on cancer and infectious diseases. The platform's modularity and tailored hyper-targeting capabilities are key differentiators, offering a versatile foundation for creating next-generation medicines.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Nykode Therapeutics ASA and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-27 07:01 |
Regulatory News Service
Nykode Announces Updated Strategy to Increase Value for Patients and Shareholde…
|
English | 176.0 KB | |
| 2025-08-27 07:01 |
Regulatory News Service
Nykode Announces Updated Strategy to Increase Value for Patients and Shareholde…
|
English | 12.9 KB | |
| 2025-08-27 07:00 |
Interim Report
Nykode Therapeutics - Quarterly report Q2 2025 - Attachment: 250827 Nykode Quar…
|
English | 11.4 MB | |
| 2025-08-27 07:00 |
Report Publication Announcement
Nykode Therapeutics - Quarterly report Q2 2025
|
English | 3.0 KB | |
| 2025-08-20 08:00 |
Report Publication Announcement
Nykode Therapeutics – Invitation to Q2 2025 Financial Results Presentation and …
|
English | 125.6 KB | |
| 2025-08-20 08:00 |
Report Publication Announcement
Nykode Therapeutics – Invitation to Q2 2025 Financial Results Presentation and …
|
English | 3.3 KB | |
| 2025-07-09 18:15 |
Director's Dealing
Nykode Therapeutics – Grant of Share Options - Attachment: Attachment 250709.pdf
|
English | 213.3 KB | |
| 2025-07-09 18:15 |
Remuneration Information
Nykode Therapeutics – Grant of Share Options
|
English | 1.1 KB | |
| 2025-07-04 16:41 |
Report Publication Announcement
Financial calendar
|
English | 508 bytes | |
| 2025-05-28 07:00 |
Quarterly Report
Nykode Therapeutics - Quarterly report Q1 2025 - Attachment: 250528 Nykode Quar…
|
English | 4.3 MB | |
| 2025-05-28 07:00 |
Report Publication Announcement
Nykode Therapeutics - Quarterly report Q1 2025
|
English | 3.0 KB | |
| 2025-05-27 07:00 |
Notice of Dividend Amount
Nykode Therapeutics ASA - Ex-dividend NOK 1.00 today
|
English | 490 bytes | |
| 2025-05-26 16:51 |
Report Publication Announcement
Nykode Therapeutics – invitation to Q1 2025 financial results presentation - A…
|
English | 125.5 KB | |
| 2025-05-26 16:51 |
Report Publication Announcement
Nykode Therapeutics – invitation to Q1 2025 financial results presentation
|
English | 3.2 KB | |
| 2025-05-26 11:25 |
Post-Annual General Meeting Information
Nykode Therapeutics ASA - Minutes of Annual General Meeting - Attachment: 25052…
|
English | 297.9 KB |
Automate Your Workflow. Get a real-time feed of all Nykode Therapeutics ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Nykode Therapeutics ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
